Showing results (101-110 of 529) with videos related to

Sort By:
Pageof 53
European Heart Journal. Cardiovascular Pharmacotherapy|July 18, 2023
Cardiovascular events in patients treated with bempedoic acid vs. placebo: systematic review and meta-analysisDavid Mutschlechner, Maximilian Tscharre, Kurt Huber, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 17, 2023
Platelet inhibition with orodispersible ticagrelor in acute coronary syndromes according to morphine use: the TASTER study final resultsGuido Parodi, Filippo Dossi, Mario Raccis, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 9, 2023
Novel therapeutic targets and emerging treatments for atherosclerotic cardiovascular diseaseWayne C Zheng, William Chan, Anthony Dart, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 4, 2023
Impact of P-glycoprotein and CYP3A4-interacting drugs on clinical outcomes in patients with atrial fibrillation using non-vitamin K antagonist oral anticoagulants: a nationwide cohort studyMaxim Grymonprez, Laura Carnoy, Andreas Capiau, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|June 16, 2023
Triglycerides revisited: is hypertriglyceridaemia a necessary therapeutic target in cardiovascular disease?Heinz Drexel, Juan Tamargo, Juan Carlos Kaski, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 30, 2026
Effect of intensive blood pressure and blood glucose control on cardiovascular outcomes driven by reductions in cardiovascular death and nephropathy: Win ratio analysis of ADVANCE TrialSeverine Bompoint, Laurent Billot, Anushka Patel, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 8, 2026
Effectiveness and Safety of SGLT2 Inhibitor Initiation in Sacubitril-Valsartan Users with Heart Failure: A Population-Based Cohort StudyChe-Yuan Wu, Baiju R Shah, Justin A Ezekowitz, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 31, 2026
When Randomization Is Not Enough: Divergent Beta-Blocker Trials and the Illusion of Universal CausalityElmir Omerovic, Truls Råmunddal, Sandeep Jha, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 10, 2026
Eplerenone vs. spironolactone in heart failure: long-term cardiorenal and mortality outcomes in a registry-based cohortKarl Wärnberg, Carl Haggård, Karin Bergen, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 15, 2026
Real-world analysis of adherence, persistence, and outcomes in patients receiving four-drug antihypertensive therapyGiuseppe Mancia, Sofie Brouwers, Silvia Calabria, et al.
Pageof 53